These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 26585744)
1. [Benefits and risks for primary prevention with statins in the elderly]. Joseph JP; Afonso M; Berdaï D; Salles N; Bénard A; Gay B; Bonnet F Presse Med; 2015 Dec; 44(12 Pt 1):1219-25. PubMed ID: 26585744 [TBL] [Abstract][Full Text] [Related]
2. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice. Bruckert E; Ferrières J Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429 [TBL] [Abstract][Full Text] [Related]
3. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial. Bonnet F; Bénard A; Poulizac P; Afonso M; Maillard A; Salvo F; Berdaï D; Salles N; Rousselot N; Marchi S; Hayes N; Joseph JP Trials; 2020 Apr; 21(1):342. PubMed ID: 32307005 [TBL] [Abstract][Full Text] [Related]
4. Statin therapy for primary prevention of cardiovascular disease. Taylor FC; Huffman M; Ebrahim S JAMA; 2013 Dec; 310(22):2451-2. PubMed ID: 24276813 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants. Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508 [TBL] [Abstract][Full Text] [Related]
6. Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis. Teng M; Lin L; Zhao YJ; Khoo AL; Davis BR; Yong QW; Yeo TC; Lim BP Drugs Aging; 2015 Aug; 32(8):649-61. PubMed ID: 26245770 [TBL] [Abstract][Full Text] [Related]
7. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis. Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343 [TBL] [Abstract][Full Text] [Related]
8. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials. Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130 [TBL] [Abstract][Full Text] [Related]
9. Statins in the elderly: an answered question? Zoungas S; Curtis A; Tonkin A; McNeil J Curr Opin Cardiol; 2014 Jul; 29(4):372-80. PubMed ID: 24866986 [TBL] [Abstract][Full Text] [Related]
11. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Ali R; Alexander KP Am J Geriatr Pharmacother; 2007 Mar; 5(1):52-63. PubMed ID: 17608248 [TBL] [Abstract][Full Text] [Related]
12. Statin Prescribing in the Elderly: Special Considerations. Leya M; Stone NJ Curr Atheroscler Rep; 2017 Oct; 19(11):47. PubMed ID: 29019063 [TBL] [Abstract][Full Text] [Related]
13. Meta-Analyses of Statin Therapy for Primary Prevention Do Not Answer Key Questions: An Empirical Appraisal of 5 Years of Statin Meta-Analyses. Huded C; Prasad V Am J Cardiovasc Drugs; 2015 Dec; 15(6):379-86. PubMed ID: 26141958 [TBL] [Abstract][Full Text] [Related]
14. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention? Mora S; Ridker PM Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935 [TBL] [Abstract][Full Text] [Related]
15. Statins and all-cause mortality in high-risk primary prevention: a second look at the results. Chodick G; Shalev V Arch Intern Med; 2010 Dec; 170(22):2041-2; author reply 2043-4. PubMed ID: 21149767 [No Abstract] [Full Text] [Related]
16. Statins for the primary prevention of cardiovascular disease in the elderly. Lowe RN; Vande Griend JP; Saseen JJ Consult Pharm; 2015 Jan; 30(1):20-30. PubMed ID: 25591028 [TBL] [Abstract][Full Text] [Related]
17. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies. Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M; BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589 [TBL] [Abstract][Full Text] [Related]
18. Are statins effective in high-risk primary prevention? Dentali F; Guasti L Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769 [No Abstract] [Full Text] [Related]
19. [Should we prescribe statins for primary prevention of cardiovascular risk? Rather yes]. Béliard-Lasserre S Rev Prat; 2016 Mar; 66(3):332-334. PubMed ID: 30512650 [TBL] [Abstract][Full Text] [Related]
20. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease. Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]